Naziv |
Akcije |
Monteiro, Pedro ; Bergenstal, M. Richard ; Toural, Elvira ; Inzucchi, E. Silvio ; Zinman, Bernard ; Hantel, Stefan ; Giljanovic Kiš, Sanja ; Kaspers, Stefan ; George, T. Jyothis ; Fitchett, David
Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial // Age and ageing, 48 (2019), 6; 859-866. doi: 10.1093/ageing/afz096 |
|
Giljanovic Kis, Sanja ; Khunti, Kamlesh ; Maldonado, Mario ; Del Parigi, Angelo ; Götz, Sophia ; Lee, Christopher
Linagliptin (LINA) as Add-on to Empagliflozin (EMPA) and Metformin in Patients with Type 2 Diabetes (T2DM): Subgroup Analysis by Baseline Demographics in Two 24-Week Randomized, Double Blind, Parallel-Group Trials // Diabetes (New York, N.Y.). 2016. str. A297-A297 |
|
RIDDERSTRÅLE, MARTIN ; TOURAL, ELVIRA ; FITCHETT, DAVID ; GILJANOVIC KÎS, SANJA ; WOERLE, HANS JURGEN ; MATTHEUS, MICHAELA ; ZINMAN, BERNARD ; INZUCCHI, SILVIO E.
Effect of Empagliflozin on Cardiovascular Death in Subgroups by Age: Results from EMPA-REG OUTCOME® // Diabetes (New York, N.Y.). 2016 |
|
Romera, Irena ; Ampudia-Blasco, Francisco Javier ; Pérez, Antonio ; Arino, Bernat ; Pfarr, Egon ; Giljanović Kis, Sanja ; Naderali, Ebrahim
Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus // Endocrinología y nutrición, 63 (2016), 10; 519-526. doi: 10.1016/j.endonu.2016.06.003 |
|
Romera, Irene ; Gomis, Ramon ; Crowe, Susanne ; de Pablos-Velasco, Pedro ; Aranda, Unai ; García, Arantxa ; Giljanovic Kis, Sanja ; Naderali, Ebrahim
Empagliflozin in combination with oral agents in young and overweight/obese Type 2 diabetes mellitus patients: A pooled analysis of three randomized trials // Journal of diabetes and its complications, 30 (2016), 8; 1571-1576. doi: 10.1016/j.jdiacomp.2016.07.016 |
|
Roden, Michael ; Lund, Soeren ; Pfarr, Egon ; Kohler, Sven ; Naderali, Ebrahim ; Giljanovic Kiš, Sanja
Efficacy and safety of empagliflozin by baseline age in patients with type 2 diabetes // IDF 2015: Abstracts. 2015. str. Abstract:0368-PD-x |
|
Muačević-Katanec, Diana ; Sertić, Jadranka ; Giljanović, Sanja ; Miličević, Zvonimir ; Metelko, Željko ; Stavljenić-Rukavina, Ana
Utjecaj polimorfizma apolipoproteina E na terapijski odgovor u bolesnika s hiperlipoproteinemijom // Liječnički vjesnik. Zagreb, 1998. str. 21-x |
|
Giljanović, Sanja ; Muačević-Katanec, Diana ; Miličević, Zvonko ; Metelko, Željko
Određivanje ranih hormonskih i metaboličkih čimbenika rizika za razvoj koronarne bolesti u mlađih muškaraca s abdominalnim tipom pretilosti. Hrvatski liječnički zbor, 1998 |
|
Huić, Mirjana ; Vrhovac, Božidar ; Francetić, Igor ; Bakran, Ivan ; Giljanović, Sanja
How safe are bioequivalence studies in healthy volunteers? // Therapie, 51 (1996), 410-413 |
|
Giljanović, Sanja ; Mikuš, D. Sikirić, Predrag ; Seiwerth, Sven ; Grabarević, Željko ; Ručman, Rudolf ; Petek, Marijan ; Miše, Maja ; Rotkvić, Ivo ; Turković, Branko ; Jagić, Vjekoslav et al.
Pentadecapeptide BPC 157 and rantidine have cytoprotective property. An effect in chronic stomach ulcers and cysteamine-duodenal ulcers in normal and gastrectomized rats // Abstracts of the Fourth Congress of the International Brain-Gut Society. Pečuh: Hungarian Academy of Sciences (MTA), 1996. str. 15-15 |
|